Mon, March 8, 2021

Alethia Young Initiated (AKBA) at Buy and Held Target at $8 on, Mar 8th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. at-buy-and-held-target-at-8-on-mar-8th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Alethia Young of Cantor Fitzgerald, Initiated "Akebia Therapeutics, Inc." (AKBA) at Buy and Held Target at $8 on, Mar 8th, 2021.

Alethia has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Eric Joseph of "JP Morgan" Downgraded from Hold to Sell on, Friday, January 29th, 2021